These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1195 related articles for article (PubMed ID: 26868660)

  • 41. Pharmacotherapy for the management of obesity.
    Patel D
    Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and tolerability of medications approved for chronic weight management.
    Fujioka K
    Obesity (Silver Spring); 2015 Apr; 23 Suppl 1():S7-11. PubMed ID: 25900872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drugs for Treating Obesity.
    Ryan DH
    Handb Exp Pharmacol; 2022; 274():387-414. PubMed ID: 34783910
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and tolerability of new-generation anti-obesity medications: a narrative review.
    Patel DK; Stanford FC
    Postgrad Med; 2018 Mar; 130(2):173-182. PubMed ID: 29388462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Session 3 (Joint with the British Dietetic Association): Management of obesity: Weight-loss interventions in the treatment of obesity.
    Hankey CR
    Proc Nutr Soc; 2010 Feb; 69(1):34-8. PubMed ID: 20003637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expert Panel Report: Guidelines (2013) for the management of overweight and obesity in adults.
    American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013
    Obesity (Silver Spring); 2014 Jul; 22 Suppl 2():S41-410. PubMed ID: 24227637
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacological management of obesity.
    Velazquez A; Apovian CM
    Minerva Endocrinol; 2018 Sep; 43(3):356-366. PubMed ID: 28462579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of weight loss strategies on gastric emptying and appetite control.
    Horner KM; Byrne NM; Cleghorn GJ; Näslund E; King NA
    Obes Rev; 2011 Nov; 12(11):935-51. PubMed ID: 21729233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current and emerging medications for overweight or obesity in people with comorbidities.
    Fujioka K
    Diabetes Obes Metab; 2015 Nov; 17(11):1021-32. PubMed ID: 26040215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting.
    Leventhal-Perek S; Shani M; Schonmann Y
    Fam Pract; 2023 Dec; 40(5-6):629-637. PubMed ID: 36477550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Obesity - an epidemic of the twenty-first century: an update for psychiatrists.
    Holt RI
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):6-15. PubMed ID: 16280333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug treatment of obesity: current status and future prospects.
    Kakkar AK; Dahiya N
    Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The risk of cardiovascular complications with current obesity drugs.
    Chao AM; Wadden TA; Berkowitz RI; Quigley K; Silvestry F
    Expert Opin Drug Saf; 2020 Sep; 19(9):1095-1104. PubMed ID: 32750250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms, Pathophysiology, and Management of Obesity.
    Heymsfield SB; Wadden TA
    N Engl J Med; 2017 Jan; 376(3):254-266. PubMed ID: 28099824
    [No Abstract]   [Full Text] [Related]  

  • 57. Weight loss maintenance.
    Grief SN; Miranda RL
    Am Fam Physician; 2010 Sep; 82(6):630-4. PubMed ID: 20842990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment.
    Chianelli M; Busetto L; Vettor R; Annibale B; Paoletta A; Papini E; Albanese A; Carabotti M; Casarotto D; De Pergola G; Disoteo OE; Grandone I; Medea G; Nisoli E; Raffaelli M; Schiff S; Vignati F; Cinquini M; Gonzalez-Lorenzo M; Fittipaldo VA; Minozzi S; Monteforte M; Tralongo AC; Novizio R; Persichetti A; Samperi I; Scoppola A; Borretta G; Carruba M; Carbonelli MG; De Luca M; Frontoni S; Corradini SG; Muratori F; Attanasio R
    J Endocrinol Invest; 2024 Jun; 47(6):1361-1371. PubMed ID: 38630213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New medications for obesity management: changing the landscape of obesity treatment.
    Boulghassoul-Pietrzykowska N; Franceschelli J; Still C
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):407-11. PubMed ID: 23974768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adult obesity 2: treatment and management options for weight loss and maintenance.
    Cook D
    Nurs Times; 2009 Nov; 105(46):24-6. PubMed ID: 20041616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.